Smoking History as a Predictor of Pemetrexed Monotherapy in Patients with Non-Squamous Non-Small Cell Lung Cancer.

MLA

Igawa, Satoshi, et al. “Smoking History as a Predictor of Pemetrexed Monotherapy in Patients with Non-Squamous Non-Small Cell Lung Cancer.” Oncology, vol. 91, no. 1, July 2016, pp. 41–47. EBSCOhost, https://doi.org/10.1159/000446438.

APA

Igawa, S., Sasaki, J., Otani, S., Shirasawa, M., Niwa, H., Kusuhara, S., Harada, S., Kubota, M., Katagiri, M., & Masuda, N. (2016). Smoking History as a Predictor of Pemetrexed Monotherapy in Patients with Non-Squamous Non-Small Cell Lung Cancer. Oncology, 91(1), 41–47. https://doi.org/10.1159/000446438

Chicago

Igawa, Satoshi, Jiichiro Sasaki, Sakiko Otani, Masayuki Shirasawa, Hideyuki Niwa, Seiichiro Kusuhara, Shinya Harada, Masaru Kubota, Masato Katagiri, and Noriyuki Masuda. 2016. “Smoking History as a Predictor of Pemetrexed Monotherapy in Patients with Non-Squamous Non-Small Cell Lung Cancer.” Oncology 91 (1): 41–47. doi:10.1159/000446438.